SuperSonic Imagine Receives FDA 510(k) Clearance for its new Innovative Breast and Liver package on Aixplorer - Seite 2

Other advancements with this clearance focus on breast imaging. The new breast pack combines new optimized probes and for the first time, a real time TriVu mode which combines anatomical information, stiffness information and Angio PL.U.S. microvascularization information. This mode will offer a comprehensive visualization of breast lesions that had never been proposed in the field of ultrasound.

This new imaging modes and probes cleared by FDA will be showcased on SuperSonic Imagine's booth at RSNA congress (Radiological Society of North America), from November 27 to December 1^st in Chicago.

About SuperSonic Imagine

Founded in 2005 and based in Aix-en-Provence (France), SuperSonic Imagine is a company specializing in medical imaging. The company designs, develops and markets a revolutionary ultrasound system, Aixplorer®, with an UltraFast™ platform that can acquire images 200 times faster than conventional ultrasound systems. In addition to providing exceptional image quality, this unique technology is the foundation of several innovations which have changed the paradigm of ultrasound imaging: ShearWave™ Elastography (SWE™), UltraFast™ Doppler, Angio PL.U.S- Planewave UltraSensitive™ Imaging and more recently TriVu.

ShearWave Elastography allows physicians to visualize and analyze the stiffness of tissue in a real-time, reliable, reproducible and non-invasive manner. This criteria has become an important parameter in diagnosing potentially malignant tissue or other diseased tissue. As of today, over 300 peer-reviewed publications have demonstrated the value of SWE for the clinical management of patients with a wide range of diseases. UltraFast Doppler combines Color Flow Imaging and Pulsed Wave Doppler into one simple exam, providing physicians with exam results simultaneously and helping to increase patient throughput. The latest innovation, Angio PL.U.S, provides a new level of microvascular imaging through significantly improved color sensitivity and spatial resolution while maintaining exceptional 2D imaging.

SuperSonic Imagine has been granted regulatory clearances for the commercialization of Aixplorer in key global markets. SuperSonic Imagine is a listed company since April 2014 on the Euronext, symbol SSI. 

For more information about SuperSonic Imagine, please go to www.supersonicimagine.com.

Contact information:

SuperSonic Imagine
Bernard Doorenbos
CEO
Email Contact
[phone]

NewCap
Investor Relations - EU
Pierre Laurent / Florent Alba
Email Contact
[phone]

SuperSonic Imagine
Marketing & Communication
Emmanuelle Vella
Email Contact
[phone]

Pascale Communication
Media Relations - US
Amy Phillips
Email Contact
[phone]